Tag Archives: FDA

Court Rejects FDA’s Request to Produce Pfizer Covid-19 Data at a Rate of 500 Pages Per Month. Judge Orders FDA to Produce Data at Rate of 55,000 Pages Per Month

A federal judge has rejected a request by the U.S. Food and Drug Administration (FDA) to produce data related to Pfizer’s Covid-19 drug, Comirnaty, at a rate of 500 pages per month.

Instead, the judge ordered the FDA to produce the information at a rate of 55,000 pages per month.

Continue reading “Court Rejects FDA’s Request to Produce Pfizer Covid-19 Data at a Rate of 500 Pages Per Month. Judge Orders FDA to Produce Data at Rate of 55,000 Pages Per Month”

FDA Requests 55 Years to Fully Release Pfizer’s COVID-19 Vaccine Data

In November of 2020, the U.S. Food and Drug Administration (FDA) committed to transparency, open dialogue, and efficiency when dealing with decisions to grant emergency requests for COVID-19 vaccines.

“The FDA understands there is tremendous public interest regarding vaccines for COVID-19. We remain committed to keeping the public informed about the evaluation of the data of a potential COVID-19 vaccine, so that once available, the public and the medical community can have trust and confidence in receiving the vaccine for our families and ourselves.”

FDA Commissioner Stephen M. Hahn, M.D.

Despite this promise to the American people, the FDA has now asked a United States Federal District Court for 55 years to produce the data and information it relied upon to license Pfizer’s COVID-19 vaccine, Comirnaty. To be clear, the FDA claims it conducted an intense review of these same documents in just 108 days to authorize Comirnaty in the first place.

Continue reading “FDA Requests 55 Years to Fully Release Pfizer’s COVID-19 Vaccine Data”